{"changes":[],"country":"US","description":"Crossbow Therapeutics develops TCR-mimetic antibody therapies, its T-Bolt molecules, letting off-the-shelf T-cell engagers reach intracellular cancer proteins. It serves biopharma and patients with solid and blood cancers, targeting proteins like TERT. Its edge is opening the full universe of cancer proteins as drug targets.","domain":"crossbowtherapeutics.com","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":39.78373,"lng":-100.445882,"location":"USA","name":"Crossbow Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":77000000,"currency":"USD","date":"2026-03-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"crossbowtherapeutics-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"crossbowtherapeutics.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://crossbowtherapeutics.com"},{"fact":"description","publisher":"crossbowtherapeutics.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://crossbowtherapeutics.com"}],"stage":"series-b+","techStack":[],"totalRaisedUsd":77000000,"updatedAt":"2026-05-05"}